Cargando…

IDF21-0416 Mortality risk factors due to COVID-19 in diabetic patients according to the nationwide diabetes register analysis

Detalles Bibliográficos
Autores principales:	Shestakova, M., Vikulova, O., Ajnetdinova, A., Dedov, I., Mokrysheva, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164782/ http://dx.doi.org/10.1016/j.diabres.2022.109352

Ejemplares similares

Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation
por: Shestakova, M. V., et al.
Publicado: (2022)

IDF21-0090 Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia
por: Tojieva, I., et al.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0275 Association between hyperglycemia treatment and mortality in patients with diabetes and COVID-19 in a Peruvian hospital
por: Lopez-Huamanrayme, E., et al.
Publicado: (2022)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

IDF21-0452 Virtual Diabetes Education Program for Children and Adolescents with Diabetes in Response to COVID-19 Pandemic
por: Alromaihi, D., et al.
Publicado: (2022)

Shape the future of diabetes at the IDF World Diabetes Congress 2022
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

IDF21-0080 Determinants of acceptability to COVID-19 vaccine among the general public and diabetes population in Israel
por: Kolobov, T., et al.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0663 Health-Related Quality of Life in Moroccan patients with diabetes after hospitalization for COVID-19
por: Azizi, A., et al.
Publicado: (2022)

IDF21-0273 New-Onset Diabetic Ketoacidosis as a first manifestation of Covid-19 at emergency department
por: Dhokar, R., et al.
Publicado: (2022)

IDF21-0097 Concomitant COVID-19 Infection and Ketosis Prone Diabetes. Coincidence or Relationship? A Case Report
por: Gonzalez, L., et al.
Publicado: (2022)

IDF21-0616 Observational study on covid 19 and type 1 diabetes in the Chronic Care Center Lebanon
por: Maalouf Nawfal, P., et al.
Publicado: (2022)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

COVID-19 and diabetes from IDF MENA region
por: Belkhadir, Jamal
Publicado: (2020)

IDF21-0168 Pathway to Clinical Diabetes Services in COVID-19 Era: What Has Changed and What Are the Implications?
por: Adwubi, E., et al.
Publicado: (2022)

IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19
por: Ruge, M., et al.
Publicado: (2022)

IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic
por: Quinto, C.J., et al.
Publicado: (2022)

IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
por: Veríssimo, D., et al.
Publicado: (2022)

IDF21-0190 Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes
por: Munda, A., et al.
Publicado: (2022)

IDF21-0444 Association Between Prior Antidiabetic Therapy and Outcome in Hospitalized COVID-19 Diabetic Subjects
por: Baidya, A., et al.
Publicado: (2022)

P04.16. Integrative medicine practice patterns across the US: results from a survey of 29 centers
por: Abrams, D, et al.
Publicado: (2012)

IDF21-0564 The Use of a Digital Self-Care Platform in The Control of Diabetes in People With Diabetes During the COVID-19 Pandemic
por: Jacobs, M., et al.
Publicado: (2022)

Bariatric surgery: an IDF statement for obese Type 2 diabetes
por: Dixon, J B, et al.
Publicado: (2011)

Diabetes and COVID-19: IDF perspective in the Western Pacific region
por: Hwang, Yerin, et al.
Publicado: (2020)

Quantifying the underestimation of projected global diabetes prevalence by the International Diabetes Federation (IDF) Diabetes Atlas
por: Tönnies, Thaddäus, et al.
Publicado: (2021)

Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria
por: Pokharel, Daya Ram, et al.
Publicado: (2014)

IDF21-0472 The effect of structured diabetes self-management education care on glycaemic control in Accra subsequent to COVID-19
por: Lamptey, R., et al.
Publicado: (2022)

IDF21-0498 Innovative ways to continue serving People with Type 1 Diabetes during Covid 19 pandemic
por: Abi Saad, M., et al.
Publicado: (2022)

IDF21-0353 Covid19 toe, a late manifestation of mild SARS-CoV-2 with Diabetes
por: Jain, R., et al.
Publicado: (2022)

IDF21-0288 Virtually Sugar Free: Overcoming Challenges of Managing Gestational Diabetes (GDM) during a Pandemic
por: Khurana, R., et al.
Publicado: (2022)

IDF21-0512 Development of Latent Autoimmune Diabetes of Adults Post SARS-COV-2 mRNA Vaccination
por: Kanzy, A., et al.
Publicado: (2022)

IDF21-0302 A human digital interface uniquely supports diabetes patient care during COVID 19
por: Mehrotra, R.N., et al.
Publicado: (2022)

Changes in Visual Impairment due to Diabetic Retinopathy During 1980–2019 Based on Nationwide Register Data
por: Purola, Petri K.M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h3naeus4ndgpe43bf0dlses0fj